SEP 06, 2017 09:00 AM HKT
通过对比自动化细胞扩增方法与人工方法来分析扩增骨髓间充质干细胞(MSC)的成本效益
SPONSORED BY: TERUMO BCT
4 13 503

Speakers:
  • Lead Medical Laboratory Scientist and Assistant Professor at Mayo Clinic in Jacksonville, Florida
    Biography
      Athena Russell is Lead Medical Laboratory Scientist of the Human Cellular Therapy Laboratory and Assistant Professor of Laboratory Medicine and Pathology at Mayo Clinic in Jacksonville, Florida. She has held multiple positions at Mayo Clinic, concentrating her work on mesenchymal and hematopoietic stem cell research, and other cellular and cell-derived therapies. Athena also holds elected positions with the International Society for Cellular Therapy and the American Association of Bioanalysts.

    Abstract:

    DATE: September 6, 2017 
    TIME: 9:00AM HKT

    OR 

    DATE:September 5, 2017
    TIME: 6:00PM PST

     

    将评估使用符合良好生产规范(GMP)的各种方法扩大规模,大量生产骨髓间充质干细胞(BMSC)的不同方式。
    介绍的主题将包括以自动或手动方式生产足够每位患者单剂量
    (100 × 106个BMSC细胞)使用的细胞产量、成本、时间以及难易程度。
    具体内容

    为一期和二期临床试验手动与自动生产MSC的成本效益分析


    可能感兴趣的读者
    临床医生、研究者、实验室技术员和细胞治疗行业的专业人士
    细胞治疗生产行业的专业人士

    为一期和二期临床试验手动与自动生产MSC的成本效益分析


    Show Resources
    Loading Comments...